SEC Form 4 · accession 0001144204-17-037014
BRAINSTORM CELL THERAPEUTICS INC. · BCLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Irit Arbel
Director
Period of report
Jul 13, 2017
Accepted (ET)
Jul 17, 2017 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001137883
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.75 | Jul 13, 2017 | A | 12,000 | A | Jul 13, 2018 | Jul 13, 2028 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1Option is fully vested and exercisable on the date of grant.